Skip to content
healthcare.dev

Mesalamine

NDC 65162-360, Mesalamine, tablet, delayed release, from Amneal Pharmaceuticals LLC.

Product NDC
65162-360
Status
Listed
Labeler
Amneal Pharmaceuticals LLC
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215067
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65162-360 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MESALAMINE800 mg/1

Pharmacologic classes

Aminosalicylate [EPC]; Aminosalicylic Acids [CS]

Package NDCNDC-11Package
65162-360-1865162036018180 TABLET, DELAYED RELEASE in 1 BOTTLE (65162-360-18)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/00f77203-3615-47e8-ae25-6e1cf8a2a00a
  • NADAC price for package 65162036018

    GET /v1/drugs/nadac/65162036018

Use it

Look up 65162-360 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65162-360 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65162-360. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.